Base Molecular Resonance™ Technologies Expands Detection Capabilities to Confront the Fentanyl Crisis

STUART, Fla., Sept. 10, 2025 /PRNewswire/ -- Base Molecular Resonance™ Technologies (BMRT) today announced a breakthrough in the detection of fentanyl and its chemical precursors, strengthening America's ability to confront the most lethal drug crisis in history.

More than 70,000 Americans die each year from fentanyl overdoses, a toll greater than all U.S. casualties in the Vietnam War. Fentanyl is inexpensive to manufacture, lethal in doses as small as two milligrams, and nearly impossible to stop with conventional methods. Current interdiction techniques capture only 10% to 15% of fentanyl entering the country, leaving the vast majority to devastate communities.

A Shifting Threat Landscape
Transnational criminal organizations are rapidly adapting their trafficking routes, shifting significant fentanyl production and precursor flows from the southern U.S. border to Canada. With 5,000 miles of largely unmonitored northern border and only 1% of containers inspected at the Port of Vancouver, the operational gap is widening, and so is the national security risk.

According to Robert "Bo" Short, Co-Founder & CEO of BMRT, "For the first time, we have a technology that doesn't just slow fentanyl trafficking; it can actually stop it. BMRT's breakthrough gives agencies the unprecedented ability to detect and interdict this threat in real time, before it reaches our communities."

BMRT's Validated Solution
BMRT's multi-patented Base Molecular Resonance™ (BMR™) technology delivers what traditional interdiction methods cannot: certainty. It detects narcotics and precursor chemicals at long range, even through packaging, vehicles, and containers. Scans are instant, results are real time, and independent validation confirms zero false positives.

BMRT can give agencies like DHS, FBI, CBP, and DEA persistent chemical intelligence, enabling them to detect, track, and interdict fentanyl trafficking before it can harm U.S. citizens.

To see how this game-changing technology works and hear reactions from globally recognized security authorities, CLICK HERE.

Mission-Critical Applications
BMR™ is built for the front lines of the fentanyl crisis. On the northern border, it can uncover flows across Canada-U.S. routes and containers moving through Vancouver. At the southern border and cargo ports, it can reveal concealed shipments hidden in vehicles and freight.

Inside postal facilities, it can detect fentanyl and other illegal narcotics in parcels without disrupting commerce. In the field, it protects first responders from accidental exposure. And in communities, from schools to stadiums, it acts as a shield, stopping distribution before it reaches the public.

The National Imperative
"The fentanyl crisis is not only a public health catastrophe, it is a growing national security threat," said Lee Duke, BMRT Co-Founder and President. He added, "BMRT offers the U.S. government and law enforcement agencies a game-changing advantage: the ability to see fentanyl and its precursors instantly, at distance, and without error. This technology can close the detection gap and save tens of thousands of lives every year."

BMRT's breakthrough represents a decisive step forward in the fight against fentanyl, transforming detection from a game of chance into a science of certainty.

BMRT's multi-patented Base Molecular Resonance™ (BMR™) technology has been independently validated by the Centre for Applied Innovation at York St. John University in England, demonstrating 100% accuracy in blind and double-blind tests with no false-positives or negatives, both up close and at great distances. The technology enables non-invasive, real-time detection of every element on the periodic table, over 200 cancers and other diseases, and high-threat substances including weapons, explosives, and narcotics.

BMRT currently holds 20 patent assets and has received an independent $60.3 billion intellectual property valuation across 56 global use cases.

For more information, visit www.BMRT.io

Investment Inquiries
Robert "Bo "Short
Co-Founder & CEO
[email protected]

Media Contact
Bryan Adams
Chief Marketing Officer
[email protected]

About Base Molecular Resonance™ Technologies (BMRT)
BMRT has discovered a new area of quantum physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in Cancer Diagnostics, Public Safety, Law Enforcement, National Security, and Military Services.

SOURCE Base Molecular Resonance Technologies, LLC